Literature DB >> 16169370

Prevalence of echocardiographic left ventricular hypertrophy in persons with systemic hypertension, coronary artery disease, and peripheral arterial disease and in persons with systemic hypertension, coronary artery disease, and no peripheral arterial disease.

Rishi Sukhija1, Wilbert S Aronow, Priyanka Kakar, James A Levy, Stuart G Lehrman, Sateesh Babu.   

Abstract

Echocardiographic left ventricular (LV) hypertrophy was present in 120 of 160 patients (75%) (mean age 72 +/- 8 years) with systemic hypertension, coronary artery disease, and peripheral arterial disease (PAD) and in 43 of 94 age- and gender-matched patients (46%) with systemic hypertension, coronary artery disease, and no PAD (p<0.001). Echocardiographic LV hypertrophy was present in 63 of 68 patients with PAD (93%) with ankle-brachial indexes (ABIs) of <0.60 and in 57 of 92 patients (62%) with ABIs of 0.60 to 0.89 (p<0.001).

Entities:  

Mesh:

Year:  2005        PMID: 16169370     DOI: 10.1016/j.amjcard.2005.05.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Aditya Jain; Harikrishna Tandri; Darshan Dalal; Harjit Chahal; Elsayed Z Soliman; Ronald J Prineas; Aaron R Folsom; João A C Lima; David A Bluemke
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

2.  Peripheral venous occlusion causing cardiac hypertrophy and changes in biological parameters in rats.

Authors:  Shigeo Kawada; Naokata Ishii
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

3.  Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertension.

Authors:  Oliver Bruder; Christoph J Jensen; Michael Bell; Reinhard Rummel; Guenter Boehm; Sven Klebs; Christian Sieder; Jochen Senges
Journal:  J Drug Assess       Date:  2011-12-16

4.  Individual assessment of arteriosclerosis by empiric clinical profiling.

Authors:  Marcus Mutschelknauss; Marco Kummer; Juergen Muser; Steve B Feinstein; Peter M Meyer; Barbara C Biedermann
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.